My-T Heroes Stories
Stories as unique as individual cells
CAR-T cell therapy is an individualized approach to treating certain types of cancer. This breakthrough immunotherapy, which is a type of cell and gene therapy, reprograms a patient's own T cells to detect and destroy certain kinds of advanced B-cell blood cancer.
Every person who has undergone CAR-T cell therapy has a story as unique as their individual cells. My-T Heroes: The Stories of CAR-T aims to document these patient experiences. Follow along as patients share how their own T cells were reprogrammed through the CAR-T process.
Patients should consult their care team to determine if they are eligible for a CAR-T cell therapy. As with all medical treatment, individual results may vary; not all patients will respond to treatment with CAR-T cell therapy. Individuals should work with their care team to monitor their status or treatment, as some who respond initially may relapse over time. CAR-T cell therapy is not available for all cancer types.
My-T Heroes Patient Advocacy Support
My-T Heroes is brought to you by Novartis in collaboration with the Cancer Support Community and the Emily Whitehead Foundation, independent organizations in the cancer community. Novartis is reimagining medicine to power breakthrough innovation in cell and gene therapy. We’d like to thank these organizations for their dedication in helping patients who have been impacted by cancer.